A study has found that epithelial cells derived from human amnion fluid (hAECs) are therapeutic when transplanted into laboratory mice modelling lung disease.
“Respiratory disease is a leading cause of morbidity and mortality,” said corresponding author Dr. Euan M. Wallace, director of The Ritchie Centre, Department of Obstetrics and Gynaecology at the Monash Medical Centre.
“There is an urgent need for cell—based therapies to treat respiratory diseases, and the use of cells isolated from human term placenta for regenerative medicine holds great promise,” he added.
Read the entire article at:
or go to www.ipftoday.com for more news.